Impact of pretreatment low-abundance HIV-1 drug resistance on virological failure after 1 year of antiretroviral therapy in China.

Miaomiao LiChang SongJing HuAobo DongRuihua KangYi FengHui XingYuhua RuanYiming ShaoKunxue HongLingjie Liao

Published in: The Journal of antimicrobial chemotherapy (2023)

Low-abundance PDR mutations ranging from 2% to 9% of abundance can increase the risk of virological failure. Further studies are warranted to define a clinically relevant threshold of LA-DRVs and the role of NRTI LA-DRVs.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
hiv infected patients
human immunodeficiency virus
antibiotic resistance genes
hiv aids
microbial community
wastewater treatment
hepatitis c virus
anaerobic digestion
hiv testing